Skip to main content
Signal8

Treanor Patrick

SEC insider (Form 3/4/5 filer). CIK 0001929863. Director at KalVista Pharmaceuticals, Inc. (KALV). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in FRAMINGHAM, MA.

Companies Treanor Patrick has filed insider reports for

  • KalVista Pharmaceuticals, Inc. (KALV): Director
Treanor Patrick profile photo

Treanor Patrick

CIK: 0001929863

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

KalVista Pharmaceuticals, Inc. logo
KALV

KalVista Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • KalVista Pharmaceuticals, Inc. logo
    KALV

    KalVista Pharmaceuticals, Inc.

    Jun 11, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    17K shares-
  • KalVista Pharmaceuticals, Inc. logo
    KALV

    KalVista Pharmaceuticals, Inc.

    Jun 11, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    10K shares-
  • KalVista Pharmaceuticals, Inc. logo
    KALV

    KalVista Pharmaceuticals, Inc.

    Jun 11, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    10K shares-
  • KalVista Pharmaceuticals, Inc. logo
    KALV

    KalVista Pharmaceuticals, Inc.

    Jun 11, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    30K shares-
  • KalVista Pharmaceuticals, Inc. logo
    KALV

    KalVista Pharmaceuticals, Inc.

    Oct 1, 2025
    Award

    Stock Option (right to buy)

    Direct
    30K shares-
  • KalVista Pharmaceuticals, Inc. logo
    KALV

    KalVista Pharmaceuticals, Inc.

    Oct 3, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    10K shares-

1-6 of 6